A Pilot Study Evaluating Nicotine Lozenges and Self Help

Inclusion Criteria: 1. male; 2. ≥18 years of age; 3. report ST as their primary tobacco of use; 4. have used ST daily for the past 6 months; 5. indicate that they want to quit; 6. have been provided with, understand, and have signed the informed consent. Exclusion Criteria: 1. previously enrolled in a study involving the use of the nicotine lozenge; 2. currently using or have completed using (past 30 days) any other behavioral or pharmacologic tobacco treatment program; 3. currently enrolled in another research study; 4. describe having a medical history of: a) unstable angina; b) myocardial infarction within the past 6 months; c) cardiac dysrhythmia other than medication-controlled atrial fibrillation or PSVT; or d) medically-treated or untreated hypertension with BP ≥ 180 systolic OR ≥ 100 diastolic; 5. have phenylketonuria (PKU) \[nicotine lozenges contain aspartame which is metabolized to phenylalanine and not processed in individuals with PKU\]; 6. have another member of their household already participating in this study; 7. have other medical or psychiatric conditions that would exclude the participant; 8. have a score of ≥ 15 on the Patient Health Questionnaire (PHQ-9) on the phone call pre-screen.